Morgan Stanley Reaffirms “Equal Weight” Rating for Hims & Hers Health (NYSE:HIMS)
Hims & Hers Health (NYSE:HIMS – Get Free Report)‘s stock had its “equal weight” rating reissued by analysts at Morgan Stanley in a research note issued to investors on Wednesday,Benzinga reports. They currently have a $40.00 target price on the stock. Morgan Stanley’s price target would indicate a potential downside of 29.69% from the stock’s […]
Hims & Hers Health (NYSE:HIMS – Get Free Report)‘s stock had its “equal weight” rating reissued by analysts at Morgan Stanley in a research note issued to investors on Wednesday,Benzinga reports. They currently have a $40.00 target price on the stock. Morgan Stanley’s price target would indicate a potential downside of 29.69% from the stock’s […]
